Growth Guidance Sparks Buzz: Recent discussions on social media about Intuitive Surgical have centered on the company’s updated 2025 growth guidance, raised to an impressive 17-17.5%. Many are pointing to the firm’s dominant position in robotic surgery as a key driver, even amidst rising competition. The enthusiasm reflects confidence in the company’s ability to maintain its edge.
Innovation in Focus: There’s also notable chatter around the broader trend of robotic-assisted surgery and recent FDA clearance for expanded use of the da Vinci Single Port system. Some discussions highlight the stock’s strong momentum and potential for expansion into new surgical fields. The conversation remains lively with a focus on technological advancements.
Note: This discussion summary was generated from an AI condensation of post data.
Intuitive Surgical Insider Trading Activity
Intuitive Surgical insiders have traded $ISRG stock on the open market 33 times in the past 6 months. Of those trades, 0 have been purchases and 33 have been sales.
Here’s a breakdown of recent trading of $ISRG stock by insiders over the last 6 months:
- GARY S GUTHART (Executive Chair of the Board o) has made 0 purchases and 8 sales selling 94,459 shares for an estimated $49,513,559.
- DAVID J. ROSA (Chief Executive Officer (CEO)) sold 24,500 shares for an estimated $13,414,979
- HENRY L CHARLTON (EVP & Chief Commercial and Mkt) has made 0 purchases and 5 sales selling 13,731 shares for an estimated $7,963,980.
- MYRIAM CURET (EVP & Chief Medical Officer) has made 0 purchases and 8 sales selling 12,521 shares for an estimated $6,619,381.
- MARK BROSIUS (SVP & Chief Mfg and Supply Cha) has made 0 purchases and 3 sales selling 5,428 shares for an estimated $2,972,118.
- BRIAN EDWARD MILLER (EVP & Chief Digital Officer) has made 0 purchases and 2 sales selling 3,500 shares for an estimated $2,012,500.
- CRAIG H BARRATT has made 0 purchases and 2 sales selling 2,943 shares for an estimated $1,636,785.
- FREDRIK WIDMAN (VP Corporate Controller) has made 0 purchases and 2 sales selling 2,067 shares for an estimated $1,136,850.
- AMY L LADD has made 0 purchases and 2 sales selling 671 shares for an estimated $305,588.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Intuitive Surgical Revenue
Intuitive Surgical had revenues of $2.5B in Q3 2025. This is an increase of 22.91% from the same period in the prior year.
You can track ISRG financials on Quiver Quantitative's ISRG stock page.
Intuitive Surgical Congressional Stock Trading
Members of Congress have traded $ISRG stock 5 times in the past 6 months. Of those trades, 3 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $ISRG stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 11/18.
- SENATOR MARKWAYNE MULLIN purchased up to $100,000 on 09/24.
- REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 09/03.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 07/10 and 1 sale worth up to $15,000 on 07/16.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Intuitive Surgical Hedge Fund Activity
We have seen 1,006 institutional investors add shares of Intuitive Surgical stock to their portfolio, and 1,144 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO removed 4,175,405 shares (-54.4%) from their portfolio in Q3 2025, for an estimated $1,867,366,378
- FMR LLC removed 3,659,932 shares (-42.3%) from their portfolio in Q3 2025, for an estimated $1,636,831,388
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,899,223 shares (+84.4%) to their portfolio in Q3 2025, for an estimated $1,296,619,502
- D. E. SHAW & CO., INC. added 1,388,122 shares (+220.1%) to their portfolio in Q3 2025, for an estimated $620,809,802
- CAPITAL RESEARCH GLOBAL INVESTORS removed 1,302,661 shares (-45.6%) from their portfolio in Q3 2025, for an estimated $582,589,079
- WCM INVESTMENT MANAGEMENT, LLC removed 1,189,761 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $646,528,025
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 1,146,204 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $512,616,814
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Intuitive Surgical Government Contracts
We have seen $19,247,250 of award payments to $ISRG over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- EXPRESS REPORT: NX ORDERS PLACE FROM MARCH, 2024 THROUGH DECEMBER, 2024: $14,398,185
- 8511346118!DAVINCI MAINTENANCE - 4TH QTR: $512,000
- 8511321272!MEDICAL CAPITAL EQUIPMENT - I: $318,000
- PREVENTATIVE MAINTENANCE AGREEMENT FOR THE DAVINCI XI ROBOT USED FOR PROSTATECTOMY AND PARTIAL NEPHRECTOMY ...: $165,000
- 8511286764!DAVINCI MAINTENANCE - 4TH QTR: $159,000
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
Intuitive Surgical Analyst Ratings
Wall Street analysts have issued reports on $ISRG in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 12/18/2025
- RBC Capital issued a "Outperform" rating on 12/17/2025
- Piper Sandler issued a "Overweight" rating on 10/22/2025
- Wells Fargo issued a "Overweight" rating on 10/22/2025
- BTIG issued a "Buy" rating on 10/22/2025
- Raymond James issued a "Outperform" rating on 10/22/2025
To track analyst ratings and price targets for Intuitive Surgical, check out Quiver Quantitative's $ISRG forecast page.
Intuitive Surgical Price Targets
Multiple analysts have issued price targets for $ISRG recently. We have seen 9 analysts offer price targets for $ISRG in the last 6 months, with a median target of $603.0.
Here are some recent targets:
- Richard Newitter from Truist Securities set a target price of $650.0 on 12/18/2025
- Shagun Singh from RBC Capital set a target price of $650.0 on 12/17/2025
- Joanne Wuensch from Citigroup set a target price of $635.0 on 12/11/2025
- Danielle Antalffy from UBS set a target price of $600.0 on 10/23/2025
- Adam Maeder from Piper Sandler set a target price of $610.0 on 10/22/2025
- Ryan Zimmerman from BTIG set a target price of $589.0 on 10/22/2025
- Jayson Bedford from Raymond James set a target price of $603.0 on 10/22/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
